[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL2707010T3 - Szczepy bakteryjne należące do rodzaju bifidobacterium do zastosowania w leczeniu hipercholesterolemii - Google Patents

Szczepy bakteryjne należące do rodzaju bifidobacterium do zastosowania w leczeniu hipercholesterolemii

Info

Publication number
PL2707010T3
PL2707010T3 PL12731650T PL12731650T PL2707010T3 PL 2707010 T3 PL2707010 T3 PL 2707010T3 PL 12731650 T PL12731650 T PL 12731650T PL 12731650 T PL12731650 T PL 12731650T PL 2707010 T3 PL2707010 T3 PL 2707010T3
Authority
PL
Poland
Prior art keywords
hypercholesterolaemia
treatment
bacterial strains
strains belonging
genus bifidobacterium
Prior art date
Application number
PL12731650T
Other languages
English (en)
Inventor
Giovanni Mogna
Gian Paolo Strozzi
Luca Mogna
Original Assignee
Probiotical S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical S.P.A. filed Critical Probiotical S.P.A.
Publication of PL2707010T3 publication Critical patent/PL2707010T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12731650T 2011-05-09 2012-05-09 Szczepy bakteryjne należące do rodzaju bifidobacterium do zastosowania w leczeniu hipercholesterolemii PL2707010T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000792A ITMI20110792A1 (it) 2011-05-09 2011-05-09 Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.

Publications (1)

Publication Number Publication Date
PL2707010T3 true PL2707010T3 (pl) 2017-03-31

Family

ID=44554463

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12731650T PL2707010T3 (pl) 2011-05-09 2012-05-09 Szczepy bakteryjne należące do rodzaju bifidobacterium do zastosowania w leczeniu hipercholesterolemii

Country Status (11)

Country Link
US (2) US9925224B2 (pl)
EP (1) EP2707010B1 (pl)
JP (1) JP6018625B2 (pl)
CN (1) CN103648512B (pl)
BR (1) BR112013028496B1 (pl)
DK (1) DK2707010T3 (pl)
ES (1) ES2612142T3 (pl)
IT (1) ITMI20110792A1 (pl)
PL (1) PL2707010T3 (pl)
RU (1) RU2629806C2 (pl)
WO (1) WO2012153179A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012125397A2 (en) 2011-03-11 2012-09-20 Kraft Foods Global Brands Llc System and method of forming multilayer confectionery
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
EP3031930A1 (en) * 2014-12-10 2016-06-15 Biosearch S.A. Probiotic strains having cholesterol absorbing capacity, methods and uses thereof
EP3442550B1 (en) * 2016-04-14 2024-03-13 International N&H Denmark ApS Bifidobacteria for reducing food, energy and/or fat intake
EP3645023B1 (en) * 2017-06-30 2022-09-14 N.V. Nutricia Synbiotic composition for preventing hyperinsulinemia and insulin resistance
WO2019002609A1 (en) 2017-06-30 2019-01-03 N.V. Nutricia SYMBIOTIC COMPOSITION FOR THE PREVENTION OF METABOLIC DISORDERS
CA3106517A1 (en) * 2018-07-20 2020-01-23 Nutraceutical Holdings Inc. Compositions, uses and methods for treatment and/or prevention of elevated cholesterol, hypercholesterolemia, and cardiovascular disease
JP7495255B2 (ja) 2020-03-19 2024-06-04 矢崎総業株式会社 電気接続箱
CN113564078B (zh) * 2021-07-29 2023-10-20 微康益生菌(苏州)股份有限公司 一株降胆固醇的乳双歧杆菌BLa80及其应用

Family Cites Families (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819838A (en) 1970-08-04 1974-06-25 Bush Boake Allen Ltd Encapsulated flavoring composition
GB1363301A (en) 1971-07-12 1974-08-14 Ilford Ltd Supersensitising combination'
JPS53121949A (en) * 1977-03-31 1978-10-24 Yakult Honsha Kk Production of drink and food containing bifidobacterium cells
DE2757370A1 (de) 1977-12-22 1979-07-05 Bayer Ag Gasdichte kunststoff-aluminium-verbundfolien
CH637297A5 (fr) 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
JPS58152809A (ja) 1982-03-05 1983-09-10 Eisai Co Ltd 安定な発泡性「膣」坐剤
US4670272A (en) 1985-11-08 1987-06-02 Frito-Lay, Inc. Thermostable creme
EP0231585B1 (en) 1986-02-06 1992-07-08 Celgene Corporation Biosynthesis of heteropolysaccharides
US5413960A (en) 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
UA39965C2 (uk) 1993-12-03 2001-07-16 Лайфор Леборетріз Лтд Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти )
CN1211188A (zh) 1996-02-14 1999-03-17 普罗克特和甘保尔公司 用于泌尿生殖道和肠道疾病的组合物
EP0881905A1 (en) 1996-02-14 1998-12-09 The Procter & Gamble Company Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
US8828432B2 (en) 1996-10-28 2014-09-09 General Mills, Inc. Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
EP0845350A1 (de) 1996-11-29 1998-06-03 Alusuisse Technology & Management AG Kalt-verformbare Verbundfolie
CA2281473C (en) 1997-02-20 2007-01-16 Therics, Inc. Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
HU9701081D0 (en) 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
FR2765078B1 (fr) 1997-06-27 1999-09-17 Guyomarc H Nutrition Animale Procede d'amelioration de l'efficacite d'un probiotique, preparation d'additifs alimentaires et aliments pour animaux la contenant
DE69929321T2 (de) * 1998-04-01 2006-09-14 Ganeden Biotech, Inc., San Diego Erfahren zür verringerung von cholesterin mit bacillus coagulans sporen, systeme un zusammensetzungen
US6262019B1 (en) 1998-04-30 2001-07-17 Vit-Immune, L. C. Method of treatment of glutathione deficient mammals
PT956858E (pt) 1998-04-30 2002-04-29 Renata Maria Anna Caval Vesely Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
BR9916062A (pt) 1998-12-11 2002-09-24 Urex Biotech Inc Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital
RU2150268C1 (ru) 1998-12-25 2000-06-10 Быков Валерий Алексеевич Суппозиторий с лактобактериями для лечения дисбактериозов влагалища
SE9900215D0 (sv) 1999-01-26 1999-01-26 Pharmacia & Upjohn Ab New use
CA2374937A1 (en) 1999-05-25 2000-11-30 Gregor Reid Oral administration of lactobacillus for the maintenance of health in women
IT1309427B1 (it) 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
DE19940592A1 (de) 1999-08-26 2001-03-08 Baensch Tetra Werke Portionsverpackung für Gelfutter
KR100357668B1 (ko) 2000-02-19 2002-10-18 주식회사 한국야쿠르트 헬리코박터 필로리에 대해 항균활성을 갖는 락토바실러스애시도필러스 에이치 와이 2177, 락토바실러스 카제이에이치 와이2743 및 그를 이용한 유산균 제제, 발효유
WO2002005829A2 (en) 2000-07-17 2002-01-24 Chr. Hansen A/S Methods and formultations with probiotic microorganisms and medicaments
CN1234373C (zh) 2000-09-28 2006-01-04 信谊药厂 含嗜酸乳杆菌的药物制剂及制备方法
RU2203946C1 (ru) 2001-09-12 2003-05-10 Хачатрян Ашот Папикович Штамм бактерий lactobacillus acidophilus n.v. ep 317/402-x "баланс-наринэ", используемый для приготовления противогастритного и противоязвенного кисломолочного продукта
EP1444098B1 (en) 2001-09-24 2006-03-22 Dupont Teijin Films U.S. Limited Partnership Multi-layer polymeric film for packaging ovenable meals
US20050074442A1 (en) 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
PL212647B1 (pl) 2002-03-21 2012-11-30 Bifodan As Kompozycja farmaceutyczna, szczep Lactobacillus paracasei Lbp PB01 oraz szczep Lactobacillus paracasei Lbp PB01 w polaczeniu ze szczepem Lactobacillus acidophilus Lba EB01, produkt chlonny zawierajacy te kompozycje oraz produkt nabialowy, produkt nutraceutyczny i czynnosciowy produkt zywnosciowy zawierajace ten szczep albo te dwa szczepy, a takze zastosowanie tego szczepu albo tych dwóch szczepów
SE0201214D0 (sv) 2002-04-23 2002-04-23 Jafar Mahdavi Multicultural fermented yoghurt
GB0230042D0 (en) 2002-12-23 2003-01-29 Britannia Pharmaceuticals Ltd Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation
US20040208863A1 (en) 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
CA2559596A1 (en) 2003-03-13 2004-11-25 Universite De Moncton (Bureau De Soutien A L'innovation) Antioxidant producing bacterium and uses thereof
US20040185032A1 (en) 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
WO2004089278A2 (en) 2003-04-09 2004-10-21 Dolhay Klinika Egészségügyi Kft. Sexual hygienic composition
US20050017013A1 (en) 2003-07-24 2005-01-27 Alberto Peisach Container for hot fill food packaging applications
US8871266B2 (en) 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
PT1675481E (pt) 2003-10-24 2009-01-02 Nutricia Nv Composição sinbiótica para bebés
EP1506781B1 (de) 2003-11-03 2005-02-23 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
GB0330009D0 (en) 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
GB0405406D0 (en) 2004-03-10 2004-04-21 Edko Pazarlama Tanitim Ltd Sti Anti-vaginitis compositions
EP1600060A1 (en) * 2004-05-25 2005-11-30 Cognis IP Management GmbH Oral and/or topical compositions comprising prebiotics and fatty acid
DE602004027120D1 (de) * 2004-05-25 2010-06-24 Cognis Ip Man Gmbh Orale und/oder topische Zubereitungen
WO2006013588A1 (en) 2004-08-05 2006-02-09 Anidral S.R.L. Folic acid producing bifidobacterium bacterial strains, formulations and use thereof
US20060039973A1 (en) 2004-08-19 2006-02-23 Mary Aldritt Effervescent composition including water soluble dietary fiber
EP1814995A2 (en) 2004-10-27 2007-08-08 North Carolina State University Lactobacillus acidophilus nucleic acids and uses thereof
JP2006180836A (ja) 2004-12-28 2006-07-13 Marudai Food Co Ltd 食中毒菌感染を抑制する乳酸菌、ならびにそれを含む発酵物、食品および医薬組成物
RU2270248C1 (ru) 2004-12-31 2006-02-20 Открытое акционерное общество "Лианозовский молочный комбинат" Штамм бифидобактерий bifidobacterium lactis 668, используемый для приготовления кисломолочных, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, бактериальных препаратов и косметических средств
JP4050784B2 (ja) 2005-02-03 2008-02-20 株式会社Ｎｒｌファーマ マトリックス型腸溶性・徐放性組成物
WO2006088923A2 (en) 2005-02-15 2006-08-24 Gorbach Sherwood L A food containing a probiotic and an isolated beta-glucan and methods of use thereof
DK2351492T3 (en) 2005-02-28 2014-12-01 Nutricia Nv Food composition with probiotics
KR100661032B1 (ko) 2005-04-19 2006-12-22 주식회사한국야쿠르트 간 기능 개선, 혈중 알코올 감소 및 항산화에 유효한조성물
RU2303058C2 (ru) 2005-06-10 2007-07-20 ООО "Витбиомед-плюс" Средство для лечения кишечных инфекций, осложненных дисбактериозом "биобаланс-к"
EP1733872A1 (de) 2005-06-15 2006-12-20 Alcan Technology & Management Ltd. Kaltverformbares Laminat
ES2335529T3 (es) 2005-07-21 2010-03-29 Kabushiki Kaisha Yakult Honsha Bacteria nueva que pertenece al genero bifidobacterium y utilizacion de la misma.
JP2007029773A (ja) * 2005-07-22 2007-02-08 Mikuni Corp 噴霧装置
WO2007020884A1 (ja) 2005-08-12 2007-02-22 Meiji Dairies Corporation β－ディフェンシンを介した感染予防効果を有するビフィズス菌または乳酸菌とそれを含有する食品・医薬品組成物
JP5116473B2 (ja) 2005-09-08 2013-01-09 株式会社ヤクルト本社 コレステロール吸収抑制剤
EP1775117A1 (de) 2005-10-12 2007-04-18 Alcan Technology & Management Ltd. Kaltverformbares Laminat für Blisterbodenteile
PT1940243E (pt) 2005-10-24 2011-10-17 Nestec Sa Formulação de fibras alimentares e método de administração
DE102005062731A1 (de) 2005-12-22 2007-06-28 Organobalance Gmbh Neue Lactobacillus Stämme und deren Verwendung
WO2007100765A2 (en) 2006-02-28 2007-09-07 Childrens Memorial Hospital Lysozyme-modified probiotic components and uses thereof
PL1993576T3 (pl) 2006-03-07 2016-04-29 Nestec Sa Mieszanina synbiotyczna
RU2318523C2 (ru) 2006-03-13 2008-03-10 Лев Давидович Раснецов Средство антимикробного действия
EP2269465A1 (en) * 2006-05-03 2011-01-05 Probiotical S.p.a. Compositions comprising Bifidobacterium adolescentis
ITMI20061841A1 (it) 2006-09-27 2008-03-28 Mofin S R L Colture liquide microbiche ad elevata stabilita' ed attivita' fermentativa
JP4829349B2 (ja) 2006-11-17 2011-12-07 エスセーアー・ハイジーン・プロダクツ・アーベー 微生物阻害組成物を含む衛生用テッシュ
ITMI20062286A1 (it) 2006-11-28 2008-05-29 Anidral Srl Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi
US20080175899A1 (en) 2007-01-19 2008-07-24 Ross Mairi R Formulation for promoting sinus health in nasal cavities
US20080187628A1 (en) 2007-02-02 2008-08-07 Champion Melinda L Water-Soluble, Quick-Dissolve Flavor Tablets
ITMI20070452A1 (it) 2007-03-07 2008-09-08 Anidral Srl Compressa comprendente microrganismi ed una combinazione di eccipienti e relativo procedimento di produzione
GB2460781B (en) 2007-03-28 2012-01-25 Alimentary Health Ltd Probiotic bifidobacterium strains
PL210465B1 (pl) 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
WO2008153377A1 (en) 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
US20090175843A1 (en) 2008-01-08 2009-07-09 Medical Nutrition Usa, Inc. Composition for prevention or treatment of urinary tract infection
US20090180999A1 (en) 2008-01-11 2009-07-16 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition
US20090226548A1 (en) 2008-01-11 2009-09-10 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections using a synergistic cranberry derivative and d-mannose composition
EE05340B1 (et) 2008-05-13 2010-08-16 O� Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tvi Lactobacillus plantarum Tensia DSM 21380 ja selle kasutamine antimikroobse ning verer?hku alandava probiootikuna ning ravimi valmistamiseks ning toiduaine realiseerimisaja pikendamiseks ja toiduaines kontamineerivatemi
DE102008023952A1 (de) 2008-05-16 2009-12-03 Alcan Technology & Management Ag Verpackungs-Deckfolie, Behältnis, Verpackung und Verpackungs-Produkt-Einheit
US9232813B2 (en) 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
RU2373274C1 (ru) 2008-07-15 2009-11-20 Федеральное Государственное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Штамм bifidobacterium breve ov-12, используемый для получения бактерийных препаратов, биологически активных добавок к пище, ферментированных и неферментированных пищевых продуктов, гигиенических и косметических средств
DK2318511T3 (en) 2008-08-28 2017-09-25 Chr Hansen As bacterial Preparation
US8137718B2 (en) 2008-09-19 2012-03-20 Mead Johnson Nutrition Company Probiotic infant products
EP2338976B1 (en) 2008-09-30 2017-08-16 Meiji Co., Ltd. Lactic acid bacterium having high oxalic acid decomposition ability
US20100092240A1 (en) 2008-10-09 2010-04-15 Joseph Glasser Agricultural water retention and replenishment system
RU2388479C1 (ru) 2008-11-26 2010-05-10 Государственное образовательное учреждение высшего профессионального образования "Оренбургская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО ОрГМА Росздрава) Способ коррекции гиперхолестеринемии
KR101075557B1 (ko) 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
EP2210505A1 (en) 2009-01-27 2010-07-28 Nestec S.A. Composition comprising caftaric acid and/or derivatives thereof
ES2778836T3 (es) 2009-03-05 2020-08-12 Probiotical Spa Cepas de bacterias que tienen una alta actividad antiinflamatoria
IT1400821B1 (it) 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico
EP2248908A1 (en) 2009-05-05 2010-11-10 Eurolactis Group S.A. Probiotic microorganisms isolated from donkey milk
FI20095550A0 (fi) 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
IT1397566B1 (it) 2009-05-27 2013-01-16 Probiotical Spa Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
BR112012001912A8 (pt) 2009-07-27 2017-12-05 Nestec Sa Composições nutritivas que compreendem fibra e probióticos
WO2011012932A1 (en) * 2009-07-30 2011-02-03 Compagnie Gervais Danone Use of coated sterol or stanol particles for the preparation of food compositions having a low fat content and being essentially emulsifier-free
WO2011044934A1 (en) 2009-10-14 2011-04-21 Probiotical S.P.A Probiotic bacteria strains enabling of hydrolyzing prebiotic fibers and symbiotic compositions thereof
IT1398553B1 (it) 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
ES2408954T3 (es) 2010-03-11 2013-06-24 Kloarys Investment Ltd Composición cosmética o farmacéutica tópica que comprende cepas probióticas de lactobacillus y uso de la misma
PL2585085T3 (pl) 2010-06-28 2014-10-31 Probiotical Spa Zastosowanie Lactobacilli hamujących wytwarzające gaz gram-ujemne pałeczki jelitowe izolowane od niemowląt z kolką
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
PL2685994T3 (pl) 2011-03-17 2016-05-31 Probiotical Spa Bakterie probiotyczne wykazujące aktywność przeciwutleniającą i ich zastosowanie
ITMI20110679A1 (it) 2011-04-20 2012-10-21 Giovanni Mogna Composizione comprendente batteri probiotici in grado di ripristinare l effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell iperacidita gastrica.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITRM20110475A1 (it) 2011-09-09 2013-03-10 Probiotical Spa Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
JP5665141B2 (ja) 2012-09-12 2015-02-04 株式会社明治 トロミヨーグルトの製造方法
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
ITMI20130794A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.

Also Published As

Publication number Publication date
US11110135B2 (en) 2021-09-07
DK2707010T3 (en) 2017-01-16
RU2629806C2 (ru) 2017-09-04
US20140127164A1 (en) 2014-05-08
US9925224B2 (en) 2018-03-27
EP2707010B1 (en) 2016-11-09
ITMI20110792A1 (it) 2012-11-10
ES2612142T3 (es) 2017-05-12
JP6018625B2 (ja) 2016-11-02
WO2012153179A1 (en) 2012-11-15
BR112013028496A2 (pt) 2017-01-10
BR112013028496B1 (pt) 2021-04-06
CN103648512A (zh) 2014-03-19
JP2014514358A (ja) 2014-06-19
RU2013148476A (ru) 2015-06-27
US20180236014A1 (en) 2018-08-23
CN103648512B (zh) 2018-02-13
EP2707010A1 (en) 2014-03-19

Similar Documents

Publication Publication Date Title
PL2707010T3 (pl) Szczepy bakteryjne należące do rodzaju bifidobacterium do zastosowania w leczeniu hipercholesterolemii
IL262278B (en) Diagnosis and treatments related to th2 inhibition
ZA201207377B (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
HK1218836A1 (zh) 協同細菌組合物和其製造方法和用途
GB201117313D0 (en) Bacterium for use in medicine
ZA201306998B (en) Competitive and effective bradyrhizobium japonicum strains
HK1174952A1 (en) Method for constructing novel bacterium belonging to the genus bifidobacterium
GB201120993D0 (en) Novel compounds and their use in therapy
KR101881611B1 (ko) 캄필로박터 감염을 감소시키기 위한 백신 및 방법
SI2575971T1 (sl) Kombinirani rastlinski izvlečki za uporabo pri zdravljenju okužb z mikrobi
HUE038336T2 (hu) Módosított gram-pozitív baktériumok és alkalmazásaik
EP2817304A4 (en) NOVEL COMPOUNDS AND THEIR THERAPEUTIC USE
ZA201404281B (en) Methods and products to diagnose and treat heatiness
HK1200815A1 (en) [1,2,4]triazolopyridines and their use as phospodiesterase inhibitors [124]
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
ZA201208978B (en) Probiotic strains for use in improving transepithelial resistance
HUE038830T2 (hu) Módosított gram-pozitív baktériumok és alkalmazásaik
ZA201308256B (en) Uses, methods and biological compositions of the genus paecilomyces for the control, prevention and eradication of phytoparasites in solanaceae cultures
EP2665738A4 (en) COMPOUNDS FOR TREATING BACTERIAL INFECTION
AU2011902301A0 (en) Novel Formulation and Treatment Methods
AU2011902031A0 (en) Improvements in medical treatment